- Home
- VANI vs ORKT Comparison
VANI vs ORKT Comparison
Compare VANI & ORKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- ORKT
- Stock Information
- Founded
- VANI 1998
- ORKT 2003
- Country
- VANI United States
- ORKT Singapore
- Employees
- VANI N/A
- ORKT N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ORKT
- Sector
- VANI Health Care
- ORKT
- Exchange
- VANI Nasdaq
- ORKT NYSE
- Market Cap
- VANI 69.9M
- ORKT 82.9M
- IPO Year
- VANI 2014
- ORKT 2024
- Fundamental
- Price
- VANI $1.20
- ORKT $1.12
- Analyst Decision
- VANI Strong Buy
- ORKT
- Analyst Count
- VANI 1
- ORKT 0
- Target Price
- VANI $3.00
- ORKT N/A
- AVG Volume (30 Days)
- VANI 134.7K
- ORKT 3.4M
- Earning Date
- VANI 11-13-2024
- ORKT 10-16-2024
- Dividend Yield
- VANI N/A
- ORKT N/A
- EPS Growth
- VANI N/A
- ORKT N/A
- EPS
- VANI N/A
- ORKT N/A
- Revenue
- VANI N/A
- ORKT $3,904,592.00
- Revenue This Year
- VANI N/A
- ORKT N/A
- Revenue Next Year
- VANI N/A
- ORKT N/A
- P/E Ratio
- VANI N/A
- ORKT N/A
- Revenue Growth
- VANI N/A
- ORKT N/A
- 52 Week Low
- VANI $1.01
- ORKT $1.12
- 52 Week High
- VANI $7.80
- ORKT $8.00
- Technical
- Relative Strength Index (RSI)
- VANI 43.85
- ORKT N/A
- Support Level
- VANI $1.17
- ORKT N/A
- Resistance Level
- VANI $1.23
- ORKT N/A
- Average True Range (ATR)
- VANI 0.05
- ORKT 0.00
- MACD
- VANI 0.00
- ORKT 0.00
- Stochastic Oscillator
- VANI 31.58
- ORKT 0.00
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.
About ORKT ORANGEKLOUD TECHNOLOGY INC
Orangekloud Technology Inc is a company that operates through its subsidiaries provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominately in Singapore. It derives revenue from platform subscriptions, license and products and professional services.